ArticleEndocrinology2026
Discovery proteomics identification of factors contributing to gonadotropin β expression.
Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Discovery proteomics identification of factors contributing to gonadotropin β expression.Endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH), critical for reproduction, are heterodimers of a common α subunit and unique β subunits that are limiting components in the mature hormone synthesis. GnRH from the hypothalamus regulates synthesis of LH and FSH β-subunits. Previous studies identified signaling pathways and transcription factors that mediate GnRH induction of β-subunits. However, these studies do not fully explain gonadotrope responsiveness to GnRH or mechanisms of how a single hormone can regulate 2 β-subunits differentially. We postulated additional transcription factors, coactivators, or corepressors, that are awaiting identification. To provide novel candidates, we used discovery proteomics of protein complexes that associate with gonadotropin β promoters regions that contain GnRH-responsive elements, and protein complexes that interact with transcription factors that are activated by GnRH to induce gonadotropin β genes. Data are available via ProteomeXchange with identifier PXD075636. Using computational tools, such as Intervene and Tidyproteomics, we compare and contrast proteins in complexes to identify coactivators or corepressors that may be unique or in common for both gonadotropin β subunit transcriptional upregulation or repression, novel transcription factors, and proteins that may regulate both gonadotropin β gene expression, proteins specific to each promoter, and proteins that are recruited via interaction with intermediate GnRH-induced transcription factors. Our studies can serve as a resource to interrogate potential candidates in cell cultures and in vivo for their roles in gonadotropin β expression. Understanding the mechanisms whereby GnRH regulates gonadotropin hormone levels will provide insight into the physiology and pathophysiology of the reproductive system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.